The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Desai Antal Rohit since 2021.
This trader's CIK number is 1881616.
At the time of last reporting, Desai Antal Rohit was the Director of Procept Biorobotics Corp. (stock ticker symbol PRCT).
Also see all insider trading activities at Procept Biorobotics Corp.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | PRCT | 0 | $0 | 150,000 | $9,372,674 | 26,749 | $35,576 |
2024 | PRCT | 0 | $0 | 322,222 | $26,788,094 | 0 | $0 |
2021 | PRCT | 440,000 | $11,000,000 | 0 | $0 | 0 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-08-14 | PRCT | Option Ex | 26,749 | 1.33 | 35,576 |
2025-06-10 | PRCT | Sale | 25,000 | 63.97 | 1,599,300 |
2025-06-11 | PRCT | Sale | 25,000 | 63.45 | 1,586,150 |
2025-06-12 | PRCT | Sale | 25,000 | 61.80 | 1,545,075 |
2025-06-03 | PRCT | Sale | 25,000 | 60.09 | 1,502,325 |
2025-06-04 | PRCT | Sale | 25,000 | 61.11 | 1,527,800 |
2025-06-05 | PRCT | Sale | 25,000 | 64.48 | 1,612,024 |
2024-11-05 | PRCT | Sale | 33,000 | 96.87 | 3,196,644 |
2024-11-06 | PRCT | Sale | 33,000 | 97.03 | 3,202,089 |
2024-11-07 | PRCT | Sale | 34,000 | 95.83 | 3,258,254 |
2024-09-10 | PRCT | Sale | 36,500 | 76.19 | 2,780,935 |
2024-09-11 | PRCT | Sale | 38,698 | 77.45 | 2,997,005 |
2024-09-12 | PRCT | Sale | 44,867 | 79.33 | 3,559,254 |
2024-09-03 | PRCT | Sale | 35,220 | 77.12 | 2,716,342 |
2024-09-04 | PRCT | Sale | 53,632 | 75.66 | 4,057,850 |
2024-09-05 | PRCT | Sale | 13,305 | 76.64 | 1,019,721 |
2021-09-17 | PRCT | Buy | 440,000 | 25.00 | 11,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Desai Antal Rohit (Director of Procept Biorobotics Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.